遗传背景影响小鼠慢性肾脏病的心脏表型
研究比较了两种遗传背景的Col4a3敲除小鼠慢性肾脏病模型,发现B6背景小鼠CKD进展更慢、生存期更长,且仅在20周龄出现左心室肥厚,伴随FGFR4及肥厚标志物表达增加,提示遗传背景影响心脏表型。
要点
- B6-Col4a3KO小鼠生存期长于129Sv-Col4a3KO小鼠。
- 129Sv-Col4a3KO小鼠10周龄即出现肾功能受损、高磷血症和FGF23显著升高。
- 仅20周龄B6-Col4a3KO小鼠发生左心室肥厚,伴FGFR4及肥厚标志物表达增加。
核心结论
- B6-Col4a3KO小鼠CKD进展更慢、生存期更长,可作为心肾疾病的新模型。
研究设计与样本
- 研究比较了同源Col4a3KO和野生型小鼠,分别携带75% 129X1/SvJ或94% C57Bl6/J基因组。
主要发现
- B6-Col4a3KO小鼠生存期长于129Sv-Col4a3KO小鼠(21.4 ± 0.6 versus 11.4 ± 0.4周;P < 0.05)。
- 10周龄129Sv-Col4a3KO小鼠血尿素氮191 ± 39 versus 34 ± 4 mg/dL,血磷14.1 ± 1.4 versus 6.8 ± 0.3 mg/dL,血清FGF23水平高33倍(均P < 0.05 vs WT)。
- 10周龄B6-Col4a3KO小鼠肾功能损害较轻,FGF23轻度升高,无其他矿物质代谢改变。
- 20周龄B6-Col4a3KO小鼠出现高磷血症和FGF23升高8倍(均P < 0.05 vs WT),并发生左心室肥厚(LV mass 125 ± 3 versus 98 ± 6 mg;P < 0.05 vs WT)。
- 左心室肥厚伴随心脏FGFR4 mRNA和蛋白及肥厚标志物(ANP、BNP、β-MHC)表达显著增加(均P < 0.05 vs WT)。
临床怎么用
- 选择Col4a3KO小鼠模型研究CKD相关心脏表型时需考虑遗传背景的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Levels of fibroblast growth factor 23 (FGF23) increase early in chronic kidney disease (CKD) and are independently associated with left ventricular hypertrophy (LVH), heart failure and death. Experimental models of CKD with elevated FGF23 and LVH are needed. We hypothesized that slow rates of CKD progression in the Col4a3 knockout (Col4a3KO) mouse model of CKD would promote development of LVH by prolonging exposure to elevated FGF23. METHODS: We studied congenic Col4a3KO and wild-type (WT) mice with either 75% 129X1/SvJ (129Sv) or 94% C57Bl6/J (B6) genomes. RESULTS: B6-Col4a3KO lived longer than 129Sv-Col4a3KO mice (21.4 ± 0.6 versus 11.4 ± 0.4 weeks; P < 0.05). 10-week-old 129Sv-Col4a3KO mice showed impaired renal function (blood urea nitrogen 191 ± 39 versus 34 ± 4 mg/dL), hyperphosphatemia (14.1 ± 1.4 versus 6.8 ± 0.3 mg/dL) and 33-fold higher serum FGF23 levels (P < 0.05 versus WT for each). Consistent with their slower CKD progression, 10 week-old B6-Col4a3KO mice showed milder impairment of renal function than 129Sv-Col4a3KO mice and modest FGF23 elevation without other alterations of mineral metabolism. At 20 weeks, further declines in renal function in B6-Col4a3KO mice was accompanied by hyperphosphatemia and 8-fold higher FGF23 levels (P < 0.05 versus WT for each). Only the 20-week-old B6-Col4a3KO mice developed LVH (LV mass 125 ± 3 versus 98 ± 6 mg; P < 0.05 versus WT) in association with significantly increased cardiac expression of FGF receptor 4 (FGFR4) messenger RNA and protein and markers of LVH (Atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), beta-myosin heavy chain (β-MHC); P < 0.05 versus WT for each). CONCLUSIONS: In conclusion, B6-Col4a3KO mice manifest slower CKD progression and longer survival than 129Sv-Col4a3KO mice and can serve as a novel model of cardiorenal disease.
引用
- Neuburg S, Dussold C, Gerber C, et al. Genetic background influences cardiac phenotype in murine chronic kidney disease. Nephrol Dial Transplant. 2018. PMID: 29309658. doi:10.1093/ndt/gfx332
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。